报价延迟最少15分钟:2025/09/17 10:06 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
92.63 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
2.05/2.52
|
|
企业价值
2.28B
|
| 资产负债 |
|
每股账面净值
16.02
|
| 现金流量 |
|
现金流量率
0.03
|
| 损益表 |
|
收益
219.86M
|
|
每股收益
8.20
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/09/17 10:06 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients. |
